Monday, 31 August 2026European Markets
ExploreSearch
ViaNews EU
stockMarket

DLTX Stock Bearish Momentum With A 28% Drop In The Last 21 Sessions

Loading stream...

(VIANEWS) - Shares of DLTX (Oslo Børs Benchmark Index_GI: DLTX.OL) dropped by a staggering 28.99% in 21 sessions from kr1.38 to kr0.98 at 11:21 EST on Tuesday, after two consecutive sessions in a row of gains. Oslo Børs Benchmark Index_GI is jumping 0.16% to kr1,229.17, after five consecutive sessions in a row of gains.

About DLTX

DLTx ASA, a technology company, invests in distributed ledger technology and blockchain sectors. It engages in the provision of commercial business, physical infrastructure, and software services. The company is based in Oslo, Norway.

Earnings Per Share

As for profitability, DLTX has a trailing twelve months EPS of kr-3.73.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, DLTX's stock is considered to be oversold (<=20).

Volume

Today's last reported volume for DLTX is 76087 which is 37.66% below its average volume of 703485.

More news about DLTX (DLTX.OL).

Categories

stockMarket

Tags

Stock PricePrice DownMarket Session NowDLTXStock Price DownStock Market NowMarket SessionStock MarketDLTX.OLStock
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Hawkish Fed Signals at Jackson Hole Pressure Rate-Sensitive Assets
Kevin Warsh's hawkish inflation remarks at Jackson Hole, alongside a steady drumbeat of Federal Reserve testimony from Powell, Barr, Bowman and other officials on supervision, regulation and monetary policy, signal continued vigilance against inflation rather than an imminent easing cycle. Rate-sensitive and precious-metals-linked names such as SSR Mining sold off the same day, consistent with markets repricing for a firmer-for-longer policy stance.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,979
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,979 facts checked against source5,261 source documents archived
Query this data → isubstrate.com